Insilico Medicine vs Regard

Insilico Medicine uses generative AI, deep learning, and robotics to accelerate drug discovery and development. Its Pharma.AI platform supports target identification, molecule generation, and clinical trial prediction. The company has developed multiple AI-discovered drug candidates, including therapies that have advanced into clinical trials. Insilico combines biological data, chemistry models, and automated laboratories to reduce drug development timelines. Its work focuses on oncology, fibrosis, and age-related diseases.

Regard is an AI-powered clinical insights platform designed to help healthcare providers identify diagnoses and generate more complete clinical documentation. The platform analyzes patient records and surfaces relevant clinical findings at the point of care. It helps clinicians improve documentation accuracy, reduce administrative burden, and capture missed diagnoses. Regard reviews large amounts of patient data to provide actionable recommendations before and during patient visits. The platform is used by hospitals and health systems to improve care quality and operational performance. Its primary focus is proactive clinical decision support and documentation enhancement.